Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.02
+0.20 (3.44%)
At close: Oct 26, 2026, 4:00 PM EDT
6.05
+0.03 (0.50%)
Pre-market: Oct 27, 2026, 8:59 AM EDT
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of $575.81 million as of October 26, 2026. It is the 13,520th most valuable company in the world and the 2,641st biggest in the United States. Its market cap has decreased by 24.07% in one year.
Market Cap
575.81M
Enterprise Value
671.11M
1-Year Change
-24.07%
Global Rank
Country Rank
#2,641 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $575.81M, an increase of 462.86%. That is a compound annual growth rate of 6.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 575.81M | 0.44% |
| Dec 31, 2025 | 573.30M | -54.07% |
| Dec 31, 2024 | 1.25B | -20.67% |
| Dec 29, 2023 | 1.57B | 33.81% |
| Dec 30, 2022 | 1.18B | -46.65% |
| Dec 31, 2021 | 2.20B | 48.19% |
| Dec 31, 2020 | 1.49B | -26.57% |
| Dec 31, 2019 | 2.03B | -6.80% |
| Dec 31, 2018 | 2.17B | -8.61% |
| Dec 29, 2017 | 2.38B | 108.51% |
| Dec 30, 2016 | 1.14B | -62.13% |
| Dec 31, 2015 | 3.01B | 21.14% |
| Dec 31, 2014 | 2.49B | 58.51% |
| Dec 31, 2013 | 1.57B | -29.30% |
| Dec 31, 2012 | 2.22B | 25.03% |
| Dec 30, 2011 | 1.77B | -15.91% |
| Dec 31, 2010 | 2.11B | -15.93% |
| Dec 31, 2009 | 2.51B | -18.54% |
| Dec 31, 2008 | 3.08B | 50.95% |
| Dec 31, 2007 | 2.04B | 64.00% |
| Dec 29, 2006 | 1.24B | 93.29% |
| Dec 30, 2005 | 643.90M | -6.71% |
| Dec 31, 2004 | 690.20M | 98.11% |
| Dec 31, 2003 | 348.40M | -0.17% |
| Dec 31, 2002 | 349.00M | -71.84% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 2.14B |
| GeneDx Holdings | 1.83B |
| Personalis | 1.70B |
| Freenome | 1.37B |
| OPKO Health | 1.22B |
| Castle Biosciences | 1.02B |
| Fulgent Genetics | 556.36M |
| Biodesix | 224.32M |